Scientific considerations for complex drugs in light of established and emerging regulatory guidance.
Saved in:
| Title: | Scientific considerations for complex drugs in light of established and emerging regulatory guidance. |
|---|---|
| Authors: | Holloway C; ERA Consulting Group, Walsrode, Germany., Mueller-Berghaus J, Lima BS, Lee SL, Wyatt JS, Nicholas JM, Crommelin DJ |
| Source: | Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2012 Dec; Vol. 1276, pp. 26-36. Date of Electronic Publication: 2012 Nov 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: New York Academy of Sciences Country of Publication: United States NLM ID: 7506858 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1749-6632 (Electronic) Linking ISSN: 00778923 NLM ISO Abbreviation: Ann N Y Acad Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 23193987 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Scientific considerations for complex drugs in light of established and emerging regulatory guidance. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Holloway+C%22">Holloway C</searchLink>; ERA Consulting Group, Walsrode, Germany.<br /><searchLink fieldCode="AU" term="%22Mueller-Berghaus+J%22">Mueller-Berghaus J</searchLink><br /><searchLink fieldCode="AU" term="%22Lima+BS%22">Lima BS</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+SL%22">Lee SL</searchLink><br /><searchLink fieldCode="AU" term="%22Wyatt+JS%22">Wyatt JS</searchLink><br /><searchLink fieldCode="AU" term="%22Nicholas+JM%22">Nicholas JM</searchLink><br /><searchLink fieldCode="AU" term="%22Crommelin+DJ%22">Crommelin DJ</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227506858%22">Annals of the New York Academy of Sciences</searchLink> [Ann N Y Acad Sci] 2012 Dec; Vol. 1276, pp. 26-36. <i>Date of Electronic Publication: </i>2012 Nov 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22New+York+Academy+of+Sciences%22">New York Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7506858 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1749-6632 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200778923%22">00778923 </searchLink><i>NLM ISO Abbreviation: </i>Ann N Y Acad Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=23193987 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/j.1749-6632.2012.06811.x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 26 Titles: – TitleFull: Scientific considerations for complex drugs in light of established and emerging regulatory guidance. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Holloway C – PersonEntity: Name: NameFull: Mueller-Berghaus J – PersonEntity: Name: NameFull: Lima BS – PersonEntity: Name: NameFull: Lee SL – PersonEntity: Name: NameFull: Wyatt JS – PersonEntity: Name: NameFull: Nicholas JM – PersonEntity: Name: NameFull: Crommelin DJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2012 Dec Type: published Y: 2012 Identifiers: – Type: issn-electronic Value: 1749-6632 Numbering: – Type: volume Value: 1276 Titles: – TitleFull: Annals of the New York Academy of Sciences Type: main |
| ResultId | 1 |